Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |